August 2021 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 -
Recent Posts
Topics
- AI (2)
- Creativity (13)
- Crowdsourcing (75)
- Diversity (10)
- Global Innovation (33)
- Health Care (19)
- Innovation (139)
- Innovation Service Providers (6)
- Internal Innovation Networks (11)
- Internet (3)
- Open Innovation (4)
- Portfolio Management (9)
- Rewards and Recognition (9)
- Science & Technology (1)
- Startups (13)
- Uncategorized (2)
Archives
- May 2024
- April 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- December 2022
- November 2022
- July 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- October 2020
- September 2020
- August 2020
- July 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- April 2019
- March 2019
- January 2019
- November 2018
- July 2018
- June 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
Social
-
- Follow on WordPress.com
Monthly Archives: August 2021
A boomerang drug
On June 7, the U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s Disease (AD), its first in nearly two decades. Manufactured by Biogen (a biotech company based in Cambridge, MA) and called Aduhelm, the drug was … Continue reading
Posted in Global Innovation, Health Care
Tagged Aduhelm, AIDS, Alzheimer’s Association, Alzheimer’s disease, Biogen, consumer-centric healthcare, FDA
Leave a comment
innovationobserver.com 